via BBC
Scientists believe they have discovered a way to “steer” the immune system to kill cancers.
Researchers at University College, London have developed a way of finding unique markings within a tumour – its “Achilles heel” – allowing the body to target the disease.
But the personalised method, reported in Science journal, would be expensive and has not yet been tried in patients.
Experts said the idea made sense but could be more complicated in reality.
However, the researchers, whose work was funded by Cancer Research UK, believe their discovery could form the backbone of new treatments and hope to test it in patients within two years.
They believe by analysing the DNA, they’ll be able to develop bespoke treatment.
People have tried to steer the immune system to kill tumours before, but cancer vaccines have largely flopped.
One explanation is that they are training the body’s own defences to go after the wrong target.
The problem is cancers are not made up of identical cells – they are a heavily mutated, genetic mess and samples at different sites within a tumour can look and behave very differently.
‘Exciting’
They grow a bit like a tree with core “trunk” mutations, but then mutations that branch off in all directions. It is known as cancer heterogeneity.
The international study developed a way of discovering the “trunk” mutations that change antigens – the proteins that stick out from the surface of cancer cells.
Professor Charles Swanton, from the UCL Cancer Institute, added: “This is exciting. Now we can prioritise and target tumour antigens that are present in every cell – the Achilles heel of these highly complex cancers.
Learn more: Breakthrough in cancer research could spawn new treatments
The Latest on: Cancer research
[google_news title=”” keyword=”cancer research” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cancer research
- Axiom-2 Mission Tasked with Testing UC San Diego Cancer Drugs and Stem Cell Researchon May 28, 2023 at 6:00 am
The Axiom-2 mission is currently docked at the International Space Station (ISS) and due to return to Earth on May 31. AXiom-2 is not only the | Space ...
- The Candle: Promising scientic progress in cancer researchon May 28, 2023 at 4:00 am
According to the American Cancer Society, the average 5-year survival rate for pancreatic cancers depends on the SEER stage, surveillance, epidemiology, and end result. SEER stages can be classified a ...
- Small business awards presented, new board member for Louisiana Cancer Research Centeron May 27, 2023 at 10:15 pm
Louisiana Economic Development and the U.S. Small Business Administration recently honored business owners and supporters at the 2023 Louisiana Small Business Awards ceremony.
- Atlanta nonprofit donates $726,000 in support of pancreatic cancer researchon May 27, 2023 at 6:00 am
The Atlanta nonprofit, Purple Pansies, is donating $726,000 towards a pancreatic cancer clinical research study. The Translational Genomics Research Institute (TGen) will run the study, which will be ...
- Piazza leading pharmacy’s innovative Cancer Research Center at Auburn Universityon May 26, 2023 at 12:38 pm
For most academic scientists conducting biomedical research, the possibility of advancing a new medicine from the lab to the clinic is, at best, an aspiration. Despite the odds, Gary Piazza and his ...
- Author Anissa Marie Bass honoring husband’s life by advocating for stomach cancer researchon May 26, 2023 at 6:00 am
Actress Anissa Marie Bass, who is also a licensed nurse, has added author to her resume as she has penned her first book, 44 Life Lessons of Hurt, Love, and Triumph. Now, after the ...
- 1st Sigma Chi Golf Classic to raise money for cancer researchon May 25, 2023 at 10:26 pm
The event is a fundraiser for research at the Huntsman Cancer Institute in Utah. It will also bring in funds for the Associate Chapter of Sigma Chi Fraternity at USM. There’s still time to register to ...
- Giovanis’ $35 million gift brings hope through cancer researchon May 24, 2023 at 1:19 pm
Ted Giovanis has carved his path through life by going against the odds. Whether it’s been beating the federal government in a court case involving Medicare reimbursements or being a competitive ...
- $250,000 to $1 million cancer research grants to be offered by Curebound; application deadline approachingon May 23, 2023 at 11:11 pm
Cancer research grants from $250,000 to $1 million are slated to be given out in 2023 by Curebound, a San Diego-based philanthropic nonprofit that supports collaborative cancer research projects. The ...
- How you can impact critical cancer researchon May 23, 2023 at 10:23 am
One in 2 men and one in 3 women have a chance of being diagnosed with cancer during their lifetimes, according to the National Cancer Institute. This is why nonprofit Stand Up to Cancer is teaming up ...
via Bing News
